ANAC - Anacor Pharmaceuticals, Inc. - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	7	20	3	4	10	34	50	88	32
P	%wins				90	90	85	70	90	55	80

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
3/23/15 18:55	3/23/15	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	EVP,CFO	P	157	52.43	33	3	1	278	I	999	135	119	64	47	23	9	-3	2	7	29	39	166	16
9/8/14 16:31	9/5/14	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	EVP,CFO	P.m	144	21.82	11	7	3	267	I	256	109	4	41	31	7	-3	-6	5	11	3	61	123	505
3/24/14 18:41	3/24/14	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	101	20.11	10	5	2	259	I	252	338	107	27	24	5	4	-5	-2	-3	-11	-15	23	147
3/19/14 19:53	3/18/14	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	54	22.60	9	2	1	254	I	289	483	117	29	31	15	6	11	6	-10	-28	-22	14	153
11/27/13 16:28	11/26/13	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	134	13.40	4	10	4	251	I	170	144	134	35	26	6	-2	5	6	13	27	43	2	161
11/26/13 16:32	11/25/13	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	128	12.85	4	10	4	241	I	147	137	124	29	18	-2	-11	2	-2	0	28	46	6	153
8/13/13 21:06	8/13/13	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	417	8.34	2	50	50	151	I	49	39	145	39	49	20	6	2	16	22	28	44	125	134
6/19/13 18:43	6/19/13	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	120	5.20	2	23	30	100	I	-11	8	5	38	-19	-9	-1	-8	0	6	36	101	226	233
6/18/13 20:44	6/18/13	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	104	5.22	2	20	35	77	I	-17	8	0	30	-24	-17	-2	-11	0	7	32	103	244	235
8/24/12 12:07	8/22/12	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	31	6.19	0	5	10	56	D		26	3	13	6	0	-1	-4	2	2	13	-11	-48	63
6/5/12 19:21	6/4/12	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P.m	38	4.81	0	8	19	50	D		-18	-5	-11	-12	-10	-8	-7	2	1	29	29	13	7
3/20/12 18:13	3/19/12	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P.m	61	6.08	1	10	31	42	D		-12	-2	-1	-16	1	9	5	2	6	-9	-17	4	-21
5/24/11 15:44	5/23/11	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P.m	60	5.95	0	10	50	30	D				-19	-10	-2	-8	-5	2	7	1	-27	-5	-11
5/11/11 17:06	5/10/11	ANAC	Health	Drug	Pharmaceutical Preparations	Parker Geoffrey M.	CA	O	SVP,CFO	P	123	6.17	0	20	New	20	D				-16	-14	-1	-7	5	9	1	2	-6	11	-7
12/2/10 15:10	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Venrock Associates IV L P	CA	T		P.d	3,000	5.00	2	600	30	2,626	I								0	3	2	6	50	15	-1
12/2/10 15:09	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Hove Anders D	CA	DT		P.d	3,000	5.00	2	600	15	4,626	I								0	3	2	6	50	15	-1
12/2/10 12:01	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Rho Ventures IV Qp LP	NY	T		P.d	12,000	5.00	2	2,400	75	5,621	I								0	3	2	6	50	15	-1
12/1/10 18:08	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Aberdare Ventures Ii, L.P.	CA	T		P.d	1,500	5.00	3	300	21	1,752	I								-2	3	4	2	56	14	-2
12/1/10 18:06	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Leschly Mark	NY	DT		P.d	12,000	5.00	3	2,400	75	5,621	I								-2	3	4	2	56	14	-2
12/1/10 18:05	11/30/10	ANAC	Health	Drug	Pharmaceutical Preparations	Klingenstein Paul H	CA	D		P.d	1,500	5.00	3	300	20	1,810	M								-2	3	4	2	56	14	-2
11/24/10 12:21	11/24/10	ANAC	Health	Drug	Pharmaceutical Preparations	Glaxosmithkline Plc	X0	T		P	5,000	5.00	0	1,000	56	2,771	I

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y